ABAnn Boija

Ann Boija

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ann Boija has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Partitioning of cancer therapeutics in nuclear condensates

    by Isaac A. Klein, Ann Boija, Lena K. Afeyan, Susana Wilson Hawken, Mengyang Fan, Alessandra Dall'Agnese, Ozgur Oksuz, Jonathan E. Henninger, Krishna Shrinivas, Benjamin R. Sabari, et al.

    Drug partitioning in nuclear condensates: There is increasing interest in the function of phase-separated biomolecular condensates in cells because of their distinct properties and expanding roles in important biological processes. Klein et al. considered the fate of small-molecule therapeutics in the context of nuclear condensates (see the Perspective by Viny and Levine). They show that certain antineoplastic drugs have physicochemical properties that cause them to concentrate preferentially in condensates, both in vitro and in cancer cells. This property influences drug activity, and protein mutations that alter condensate formation can lead to drug resistance. Optimizing condensate partitioning may be valuable in developing improved therapeutics. Science , this issue p. 1386 ; see also p. 1314


  • Top Cited Papers
    Open Access

    Coactivator condensation at super-enhancers links phase separation and gene control

    by Benjamin R. Sabari, Alessandra Dall’agnese, Ann Boija, Isaac A. Klein, Eliot L. Coffey, Krishna Shrinivas, Brian J. Abraham, Nancy M. Hannett, Alicia V. Zamudio, John C. Manteiga, et al.

    Phase separation and gene control: Many components of eukaryotic transcription machinery—such as transcription factors and cofactors including BRD4, subunits of the Mediator complex, and RNA polymerase II—contain intrinsically disordered low-complexity domains. Now a conceptual framework connecting the nature and behavior of their interactions to their functions in transcription regulation is emerging (see the Perspective by Plys and Kingston). Chong et al. found that low-complexity domains of transcription factors form concentrated hubs via functionally relevant dynamic, multivalent, and sequence-specific protein-protein interaction. These hubs have the potential to phase-separate at higher concentrations. Indeed, Sabari et al. showed that at super-enhancers, BRD4 and Mediator form liquid-like condensates that compartmentalize and concentrate the transcription apparatus to maintain expression of key cell-identity genes. Cho et al. further revealed the differential sensitivity of Mediator and RNA polymerase II condensates to selective transcription inhibitors and how their dynamic interactions might initiate transcription elongation. Science , this issue p. eaar2555 , p. eaar3958 , p. 412 ; see also p. 329


  • CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II

    by Ann Boija, Dig Bijay Mahat, Aman Zare, Per-Henrik Holmqvist, Philge Philip, David J. Meyers, Philip A. Cole, John T. Lis, Per Stenberg, Mattias Mannervik


  • Open Access

    Atrophin controls developmental signaling pathways via interactions with Trithorax-like

    by Kelvin Yeung, Ann Boija, Edvin Karlsson, Per-Henrik Holmqvist, Yonit Tsatskis, Ilaria Nisoli, Damian Yap, Alireza Lorzadeh, Michelle Moksa, Martin Hirst, et al.

    Mutations in human Atrophin1, a transcriptional corepressor, cause dentatorubral-pallidoluysian atrophy, a neurodegenerative disease. Drosophila Atrophin (Atro) mutants display many phenotypes, including neurodegeneration, segmentation, patterning and planar polarity defects. Despite Atro’s critical role in development and disease, relatively little is known about Atro’s binding partners and downstream targets. We present the first genomic analysis of Atro using ChIP-seq against endogenous Atro. ChIP-seq identified 1300 potential direct targets of Atro including engrailed, and components of the Dpp and Notch signaling pathways. We show that Atro regulates Dpp and Notch signaling in larval imaginal discs, at least partially via regulation of thickveins and fringe. In addition, bioinformatics analyses, sequential ChIP and coimmunoprecipitation experiments reveal that Atro interacts with the Drosophila GAGA Factor, Trithorax-like (Trl), and they bind to the same loci simultaneously. Phenotypic analyses of Trl and Atro clones suggest that Atro is required to modulate the transcription activation by Trl in larval imaginal discs. Taken together, these data indicate that Atro is a major Trl cofactor that functions to moderate developmental gene transcription.


  • Open Access

    Erratum to: CBP binding outside of promoters and enhancers in Drosophila melanogaster

    by Philge Philip, Ann Boija, Roshan Vaid, Allison M. Churcher, David J. Meyers, Philip A. Cole, Mattias Mannervik, Per Stenberg

    [This corrects the article DOI: 10.1186/s13072-015-0042-4.].


  • Initiation of diverse epigenetic states during nuclear programming of the Drosophila body plan

    by Ann Boija, Mattias Mannervik

    Significance: Cellular memory is used to transmit information about gene activity to daughter cells and relies on epigenetic mechanisms such as feedback loops and chemical modifications to DNA and chromatin. Although epigenetic modifications have been sampled in many cell types, how epigenetic differences between cells arise is poorly understood. We show that a gene regulatory network controlling Drosophila embryogenesis is responsible for orchestrating differences in epigenetic patterns between cell types. We further discovered that different modes of RNA polymerase regulation, including poising and displacement, are linked to these distinct chromatin states. Our results provide novel insights into how transcription regulation and epigenetics are coordinated during cell specification and explain how gene regulatory networks can shape the epigenetic landscape.


  • Open Access

    CBP binding outside of promoters and enhancers in Drosophila melanogaster

    by Philge Philip, Ann Boija, Roshan Vaid, Allison M. Churcher, David J. Meyers, Philip A. Cole, Mattias Mannervik, Per Stenberg

    CREB-binding protein (CBP, also known as nejire) is a transcriptional co-activator that is conserved in metazoans. CBP plays an important role in embryonic development and cell differentiation and mutations in CBP can lead to various diseases in humans. In addition, CBP and the related p300 protein have successfully been used to predict enhancers in both humans and flies when they occur with monomethylation of histone H3 on lysine 4 (H3K4me1). Here, we compare CBP chromatin immunoprecipitation sequencing data from Drosophila S2 cells with modENCODE data and show that CBP is bound at genomic sites with a wide range of functions. As expected, we find that CBP is bound at active promoters and enhancers. In addition, we find that the strongest CBP sites in the genome are found at Polycomb response elements embedded in histone H3 lysine 27 trimethylated (H3K27me3) chromatin, where they correlate with binding of the Pho repressive complex. Interestingly, we find that CBP also binds to most insulators in the genome. At a subset of these, CBP may regulate insulating activity, measured as the ability to prevent repressive H3K27 methylation from spreading into adjacent chromatin. We conclude that CBP could be involved in a much wider range of functions than has previously been appreciated, including Polycomb repression and insulator activity. In addition, we discuss the possibility that a common role for CBP at all functional elements may be to regulate interactions between distant chromosomal regions and speculate that CBP is controlling higher order chromatin organization.


  • A time of change: Dynamics of chromatin and transcriptional regulation during nuclear programming in early Drosophila development

    by Ann Boija, Mattias Mannervik

    In order for a new organism to form, the genomes of the highly specialized egg and sperm need to be reprogrammed into a totipotent state that is capable of generating all of the cell types that comprise an organism. This reprogramming occurs by erasing chromatin modifications, leaving the cells in a naïve state, followed by the induction of specialized programming events. Pioneer factors bind to the genome prior to zygotic genome activation, followed by acetylation of histones and further chromatin specialization by the addition of methylation marks later during differentiation. Genome‐wide approaches have provided insights into the genomic and epigenomic regulation of gene expression during development, providing a new perspective on the process of cell specification and differentiation. In this review, we discuss how distal DNA and core promoter elements, RNA polymerase pausing, transcription factors, and co‐regulators interact to shape the chromatin landscape and direct tissue‐specific expression patterns during embryo development, focusing on the well‐characterized Drosophila embryo. This article is protected by copyright. All rights reserved


  • Open Access

    Preferential Genome Targeting of the CBP Co-Activator by Rel and Smad Proteins in Early Drosophila melanogaster Embryos

    by Per-Henrik Holmqvist, Ann Boija, Philge Philip, Filip Crona, Per Stenberg, Mattias Mannervik

    CBP and the related p300 protein are widely used transcriptional co-activators in metazoans that interact with multiple transcription factors. Whether CBP/p300 occupies the genome equally with all factors or preferentially binds together with some factors is not known. We therefore compared Drosophila melanogaster CBP (nejire) ChIP–seq peaks with regions bound by 40 different transcription factors in early embryos, and we found high co-occupancy with the Rel-family protein Dorsal. Dorsal is required for CBP occupancy in the embryo, but only at regions where few other factors are present. CBP peaks in mutant embryos lacking nuclear Dorsal are best correlated with TGF-ß/Dpp-signaling and Smad-protein binding. Differences in CBP occupancy in mutant embryos reflect gene expression changes genome-wide, but CBP also occupies some non-expressed genes. The presence of CBP at silent genes does not result in histone acetylation. We find that Polycomb-repressed H3K27me3 chromatin does not preclude CBP binding, but restricts histone acetylation at CBP-bound genomic sites. We conclude that CBP occupancy in Drosophila embryos preferentially overlaps factors controlling dorso-ventral patterning and that CBP binds silent genes without causing histone hyperacetylation. Development of an embryo into different cell types relies on regulation of gene expression, whereby genes are coordinately turned on or off. CBP and the related p300 protein are central regulators of gene expression in animal cells. These co-activator proteins facilitate gene activation by a multitude of transcription factors, possibly through their histone acetyltransferase activity. Consequently, loss of CBP/p300 gene function disrupts development and is lethal in mice, worms, and flies. How CBP/p300 is targeted to regulatory DNA sequences is not understood. Here, we have compared genome occupancy of CBP with 40 different transcription factors in Drosophila embryos and find that master regulators of dorsal-ventral patterning, the transcription factors Dorsal and Medea, target CBP to the genome. CBP occupies mainly active genes in embryos, where histones become acetylated. Surprisingly, the presence of CBP at silent genes does not result in histone acetylation. We find that repressive chromatin prevents histone acetylation by CBP. Our results demonstrate that CBP preferentially associates with some gene regulatory networks and that CBP binds silent genes without causing histone acetylation. These data have implications for prediction of transcriptional regulatory sequences and for understanding gene regulation by one of the most widely used co-activators in animal cells.